The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Interrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous Thromboembolism
Abstract
Background Because patients with rare familial homocystinuria who also carry factor V Leiden have an increased incidence of venous thromboembolism (VTE), we hypothesized an interrelation of moderate hyperhomocyst(e)inemia, factor V Leiden, and risk of VTE in the general population. Methods and Results In a large prospective cohort, we determined total homocysteine level and factor V Leiden mutation in baseline blood samples from 145 initially healthy men who subsequently developed VTE and among 646 men who remained free of vascular disease during a 10-year follow-up period. Hyperhomocyst(e)inemia was defined as a total homocysteine level above the 95th percentile (17.25 μmol/L). Compared with men with normal total homocysteine levels, those with hyperhomocyst(e)inemia had no increase in risk of any VTE but were at increased risk of idiopathic VTE (relative risk [RR]=3.4, P =.002). Compared with men without Leiden mutation, those with mutation were at increased risk of developing any VTE (RR=2.3, P =.005) as well as idiopathic VTE (RR=3.6, P =.0002). Compared with men with neither abnormality, those affected by both disorders had a 10-fold increase in risk of any VTE (RR=9.65, P =.009) and a 20-fold increase in risk of idiopathic VTE (RR=21.8, P =.0004). Conclusions Apparently healthy men with coexistent hyperhomocyst(e)inemia and Leiden mutation are at substantially increased risk of developing future VTEs, particularly those events considered idiopathic. In these data, the risk of VTE among doubly affected individuals was far greater than the sum of the individual risks associated with either abnormality alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J. H., den Heijer, M., Kluijtmans, L. A. J., van den Heuve, L. P., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-111 · Cited by 5,653
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Hennekens, C. H., Buring, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341801 · Cited by 2,397
Self-citationFinal Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,264
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., & Graham, I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241701 · Cited by 2,161
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Self-citationA Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Self-citationKoster, T., Vandenbroucke, J., Rosendaal, F., de Ronde, H., Briët, E., & Bertina, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80081-9 · Cited by 1,239
Cited by
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Self-citationHomocysteine and Cardiovascular Disease
Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.31 · Cited by 2,180
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09032-6 · Cited by 1,229
Homocysteine and vascular disease
Hankey, G. J., & Eikelboom, J. W. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11058-9 · Cited by 1,052
Genetic Susceptibility to Venous Thrombosis
Seligsohn, U., & Lubetsky, A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441607 · Cited by 822
Ridker, P. M. (1997) · JAMA · doi:10.1001/jama.1997.03540400055031 · Cited by 638
Self-citationThe controversy over homocysteine and cardiovascular risk
Ueland, P. M., Refsum, H., Beresford, S. A., & Vollset, S. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.324 · Cited by 517
De Stefano, V., Martinelli, I., Mannucci, P. M., Paciaroni, K., Chiusolo, P., Casorelli, I., Rossi, E., & Leone, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411104 · Cited by 482
Goldhaber, S. Z. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390207 · Cited by 428
Kujovich, J. L. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3181faa0f2 · Cited by 419
DEN HEIJER, M., LEWINGTON, S., & CLARKE, R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01141.x · Cited by 418
Klee, G. G. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.8.1277 · Cited by 384
Hyperhomocysteinemia, Atherosclerosis and Thrombosis
Cattaneo, M. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614438 · Cited by 362
Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men
Rohde, L. E. P., Hennekens, C. H., & Ridker, P. M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00491-9 · Cited by 349
Self-citationMeta-analysis of Hyperhomocysteinemia as a Risk Factor for Venous Thromboembolic Disease
Ray, J. G. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.19.2101 · Cited by 321
Risk Factors in Venous Thromboembolism
Martinelli, I. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616237 · Cited by 291
De Bree, A., Verschuren, W. M. M., Kromhout, D., Kluijtmans, L. A. J., & Blom, H. J. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.599 · Cited by 282
Impaired Homocysteine Metabolism and Atherothrombotic Disease
Durand, P., Prost, M., Loreau, N., Lussier-Cacan, S., & Blache, D. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780275 · Cited by 261
Rohde, L. E., Lee, R. T., Rivero, J., Jamacochian, M., Arroyo, L. H., Briggs, W., Rifai, N., Libby, P., Creager, M. A., & Ridker, P. M. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.11.1765 · Cited by 260
Self-citationTotal homocysteine and cardiovascular disease
Nygård, O., Vollset, S. E., Refsum, H., Brattström, L., & Ueland, P. M. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00512.x · Cited by 256
The Role of Homocysteine‐Lowering B‐Vitamins in the Primary Prevention of Cardiovascular Disease
Debreceni, B., & Debreceni, L. (2014) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12064 · Cited by 116
Metadata
- Authors
- Ridker, P. M., Hennekens, C. H., Selhub, J., Miletich, J. P., Malinow, M. R., & Stampfer, M. J.
- Venue
- Circulation
- Published
- 1997-04
- Volume
- 95
- Issue
- 7
- Pages
- 1777-1782
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1994044028
- Cited by
- 338
- References
- 42
- FWCI
- 22.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.